Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 7.234B	--
--	2025/Q1	-- / 7.170B	--
Nov 14, 2024	2024/Q4	7.045B / 6.968B	--
Aug 15, 2024	2024/Q3	6.778B / 6.670B	--
May 16, 2024	2024/Q2	6.646B / 6.535B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 7.234B--

--2025/Q1-- / 7.170B--

Nov 14, 20242024/Q47.045B / 6.968B--

Aug 15, 20242024/Q36.778B / 6.670B--

May 16, 20242024/Q26.646B / 6.535B--

Unlock Free Earnings Estimates

Open Account

Applied Materials Earnings Reports

Applied Materials | 10-K: FY2024 Annual Report

Dec 13, 2024 16:06 ET

Applied Materials | 8-K: APPLIED MATERIALS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2024 RESULTS

Nov 14, 2024 17:23 ET

Applied Materials | 10-Q: Q3 2024 Earnings Report

Aug 22, 2024 16:05 ET

Applied Materials | 8-K: APPLIED MATERIALS ANNOUNCES THIRD QUARTER 2024 RESULTS

Aug 15, 2024 16:07 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Halozyme Therapeutics

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 8, 2025

Buy

Buy
68.42%
Hold
26.32%
Sell
5.26%

Price Target

No Data

Investment Theme

Artificial Intelligence